If you study the insulin pricing issue carefully, you will find that largely the problem is government, not the market. The profit motive coupled with competit

If you study the insulin pricing issue carefully, you will find that largely the problem is government, not the market. The profit motive coupled with competition works very well to keep prices low. You need only realize the following; European firms stand at the ready to supply insulin at well below US prices today, but are prevented from doing so by the FDA. And they can do so and still turn a profit.